Wound care is an essential aspect of modern healthcare, as it helps prevent infections, complications and disabilities. However, not all wounds heal easily and some require special attention and treatment. This is where advanced wound care comes in. Advanced wound care products are designed to facilitate faster and better healing of complex wounds, such as surgical wounds, traumatic wounds, diabetic ulcers, pressure ulcers and others. These products include dressings, therapy devices and active wound care products that provide optimal moisture, oxygen, temperature and infection control for the wound site.
According to a recent report by EMR Research, the advanced wound care market size was valued at USD 10.1 billion in 2023, driven by the increased incidence of road accidents and burn injuries across the globe. The market size is anticipated to grow at a compound annual growth rate (CAGR) of 6.9% during the forecast period of 2024-2032 to achieve a value of USD 18.32 billion by 2032. The report also provides a detailed analysis of the market segmentation, growth factors, competitive landscape, market trends and future outlook.
Market Segmentation
The report segments the advanced wound care market by product type, wound type, end-user and region. By product type, the market is divided into dressings, therapy devices and active wound care. Dressings are the largest segment, accounting for more than 50% of the market share in 2023, due to their wide availability and application. Therapy devices are the fastest-growing segment, registering a CAGR of 8.2% during the forecast period, owing to their effectiveness in stimulating wound healing and reducing pain. Active wound care products are expected to witness significant growth, as they involve the use of biologics, such as growth factors, skin substitutes and stem cells, to enhance wound healing.
By wound type, the market is categorized into surgical wounds, traumatic wounds, diabetic ulcers, pressure ulcers and others. Surgical wounds are the most prevalent type of wound, affecting millions of people every year. They are also the most lucrative segment, generating more than 40% of the market revenue in 2023. Traumatic wounds are the second-largest segment, followed by diabetic ulcers, which are expected to grow at the highest CAGR of 7.5% during the forecast period, due to the rising prevalence of diabetes and its complications. Pressure ulcers and other types of wounds, such as venous ulcers and arterial ulcers, are also projected to witness considerable growth in the coming years.
By end-user, the market is classified into hospitals, clinics, and homecare settings. Hospitals are the dominant end-user segment, as they are the primary source of advanced wound care products and services. They accounted for more than 60% of the market share in 2023 and are expected to maintain their lead throughout the forecast period. Clinics are the second-largest end-user segment, followed by homecare settings, which are anticipated to grow at the fastest CAGR of 7.2% during the forecast period, due to the increasing preference for home-based wound care and the availability of portable and user-friendly devices.
Growth Factors
The report identifies the key drivers and challenges shaping the advanced wound care market. The major factors driving the market growth are:
- Increasing incidence of road accidents and burn injuries: According to the World Health Organization (WHO), more than 1.3 million people die and 20-50 million people are injured in road traffic crashes every year. Moreover, around 180,000 people die from burns every year, mostly in low- and middle-income countries. These injuries result in complex wounds that require advanced wound care products and services to prevent infections, scarring and disabilities.
- Growing prevalence of chronic wounds: Chronic wounds are wounds that do not heal within the expected time frame, usually more than three months. They are often associated with underlying conditions, such as diabetes, vascular diseases, obesity, aging and immunosuppression. According to the International Diabetes Federation (IDF), more than 460 million people had diabetes in 2019 and this number is expected to rise to 700 million by 2045. Diabetes can lead to diabetic foot ulcers, which are one of the most common and costly complications of the disease. Similarly, pressure ulcers, also known as bedsores, are a common problem for people who are bedridden, wheelchair-bound or have limited mobility. These chronic wounds pose a significant burden on the healthcare system and the patients, and require advanced wound care products and services to improve healing and quality of life.
- Technological advancements in wound care products: The advanced wound care market is witnessing a rapid innovation and development of new products and technologies that offer better outcomes and convenience for the patients and the clinicians. Some of the examples of these products and technologies are:
- They can also communicate with smartphones or other devices to provide real-time feedback and alerts.
- Negative pressure wound therapy (NPWT): This is a therapy device that applies a controlled negative pressure to the wound site, creating a vacuum that removes excess fluid, debris and bacteria, and promotes blood flow and granulation tissue formation. NPWT can be used for various types of wounds, such as surgical wounds, traumatic wounds, diabetic ulcers and pressure ulcers.
- Bioengineered skin substitutes: These are active wound care products that involve the use of living cells, such as fibroblasts, keratinocytes, stem cells or tissue-engineered skin, to replace or augment the damaged or missing skin. They can stimulate the body’s own healing process and reduce the risk of infection and rejection.
- Rising demand for minimally invasive wound healing techniques: Minimally invasive wound healing techniques are those that involve less trauma and damage to the surrounding tissues, and result in faster recovery and less scarring. They include techniques such as laser therapy, ultrasound therapy, radiofrequency therapy and cold plasma therapy. These techniques can enhance the wound healing process by stimulating cell proliferation, collagen synthesis, angiogenesis and antimicrobial activity. They can also reduce pain, inflammation and bleeding, and improve patient satisfaction and compliance.
Competitive Landscape
The report provides an overview of the key market players, their company profiles, their strategic initiatives and partnerships, and their strengths, weaknesses, opportunities and threats (SWOT) analysis. Some of the major players in the advanced wound care market are:
- 3M: 3M is a multinational conglomerate that operates in various sectors, such as industry, healthcare, consumer, safety and electronics. It offers a wide range of advanced wound care products, such as dressings, tapes, skin protectants, wound cleansers, antimicrobial products and NPWT devices. Some of its brands are Tegaderm, Coban, Cavilon, Durapore and V.A.C. 3M has a strong global presence and a diversified portfolio of products and services. It also invests heavily in research and development (R&D) and innovation, and has a number of patents and trademarks. However, it also faces intense competition from other players, as well as regulatory and legal challenges.
- Smith & Nephew plc: Smith & Nephew is a British medical device company that specializes in orthopedics, sports medicine and advanced wound care. It offers a variety of advanced wound care products, such as dressings, NPWT devices, bioactive wound care products and digital wound care solutions. Some of its brands are Allevyn, Pico, Renasys, Santyl and Leaf. Smith & Nephew has a strong market position and a loyal customer base. It also focuses on strategic acquisitions and partnerships, as well as R&D and innovation, to expand its product portfolio and market reach. However, it also faces challenges such as pricing pressure, currency fluctuations and supply chain disruptions.
- Integra LifeSciences Holdings Corporation: Integra LifeSciences is an American medical technology company that operates in two segments: Codman Specialty Surgical and Orthopedics and Tissue Technologies. It offers a range of advanced wound care products, such as dressings, skin substitutes, wound matrix, collagen products and wound closure devices. Some of its brands are Integra, PriMatrix, Omnigraft, Dermal Regeneration Template and SurgiMend. Integra LifeSciences has a strong reputation and a leading position in the skin substitute market. It also pursues organic and inorganic growth strategies, such as product launches, acquisitions and collaborations, to enhance its market presence and competitiveness. However, it also faces risks such as product recalls, regulatory compliance and litigation.
- Mölnlycke Health Care AB: Mölnlycke is a Swedish medical device company that focuses on wound care and surgical solutions. It offers a comprehensive range of advanced wound care products, such as dressings, NPWT devices, antimicrobial products and wound management systems. Some of its brands are Mepilex, Mepitel, Avance, Biogel and Hibiclens. Mölnlycke has a strong brand recognition and a loyal customer base. It also invests in R&D and innovation, and has a number of clinical studies and publications to support its products. However, it also faces challenges such as competitive pressure, regulatory changes and environmental issues.
- ConvaTec Group plc: ConvaTec is a British medical device company that operates in four segments: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Devices. It offers a wide range of advanced wound care products, such as dressings, NPWT devices, skin care products and wound assessment tools. Some of its brands are Aquacel, DuoDERM, Avelle, Sensi-Care and Versiva. ConvaTec has a strong market position and a diversified product portfolio. It also focuses on strategic initiatives, such as acquisitions, partnerships and product launches, to expand its market share and growth opportunities. However, it also faces challenges such as operational issues, competitive pressure and currency fluctuations.
- Coloplast A/S: Coloplast is a Danish medical device company that operates in four segments: Ostomy Care, Continence Care, Wound and Skin Care, and Interventional Urology. It offers a range of advanced wound care products, such as dressings, NPWT devices, wound cleansers and skin care products. Some of its brands are Biatain, Comfeel, Purilon, Sween and Triad. Coloplast has a strong market position and a loyal customer base. It also invests in R&D and innovation, and has a number of clinical trials and evidence to support its products. However, it also faces challenges such as pricing pressure, regulatory compliance and litigation.
- Medline Industries, Inc: Medline is an American privately-owned medical supply company that offers a variety of products and services for healthcare providers and consumers. It offers a range of advanced wound care products, such as dressings, NPWT devices, wound cleansers, skin care products and wound closure devices. Some of its brands are Optifoam, Exuderm, TheraHoney, Remedy and Steri-Strip. Medline has a strong market presence and a broad distribution network. It also focuses on customer satisfaction and quality improvement, and has a number of certifications and accreditations. However, it also faces challenges such as competitive pressure, regulatory changes and supply chain disruptions.
- Advanced Medical Solutions Group plc: Advanced Medical Solutions is a British medical device company that specializes in wound care and wound closure products. It offers a range of advanced wound care products, such as dressings, wound sealants, tissue adhesives and sutures. Some of its brands are ActivHeal, LiquiBand, RESORBA and LiquiSorb. Advanced Medical Solutions has a strong market position and a niche product portfolio. It also invests in R&D and innovation, and has a number of patents and trademarks. However, it also faces challenges such as competitive pressure, regulatory compliance and currency fluctuations.
Market Trends and Future Outlook
The report also highlights the current and emerging trends and the future outlook of the advanced wound care market. Some of the key trends and outlooks are:
- Adoption of advanced wound care products in emerging economies: The advanced wound care market is expected to witness a significant growth in the emerging economies, such as China, India, Brazil and South Africa, due to the increasing demand for advanced wound care products and services, driven by the rising incidence of wounds, the growing awareness and affordability of the products, and the improving healthcare infrastructure and access. The report estimates that the Asia-Pacific region will register the highest CAGR of 8.5% during the forecast period, followed by Latin America and the Middle East and Africa.
- Focus on personalized wound care solutions: The advanced wound care market is expected to shift from a one-size-fits-all approach to a more personalized and customized approach, based on the individual needs and preferences of the patients and the clinicians. This will involve the use of advanced technologies, such as artificial intelligence, machine learning, big data and analytics, to collect and analyze the wound data, such as the wound type, size, depth, location, stage, infection status and healing progress, and to provide tailored recommendations and treatment options for the optimal wound care. This will also involve the use of personalized wound care products, such as 3D-printed dressings, bioengineered skin substitutes and gene therapy, to match the specific characteristics and requirements of the wound and the patient.
- Integration of digital technologies in wound management: The advanced wound care market is expected to leverage the potential of digital technologies, such as smartphones, wearable devices, sensors, cloud computing and telemedicine, to enhance the wound management process and outcomes. These technologies will enable the remote monitoring, assessment and communication of the wound condition, as well as the delivery of timely and appropriate treatment and feedback. They will also enable the collection and sharing of the wound data and information, as well as the generation of insights and evidence for the improvement of the wound care practices and policies.
- Regulatory landscape and implications for market growth: The advanced wound care market is subject to various regulations and standards, such as the Food and Drug Administration (FDA) in the US, the European Medicines Agency (EMA) in the EU, and the International Organization for Standardization (ISO) globally. These regulations and standards aim to ensure the safety, quality and efficacy of the advanced wound care products and services, as well as to protect the rights and interests of the patients and the providers. However, they also pose challenges and barriers for the market growth, such as the lengthy and costly approval process, the stringent and varying requirements and criteria, and the potential legal and ethical issues. The report provides an overview of the regulatory landscape and its implications for the market growth, as well as the strategies and best practices for the market players to comply with and benefit from the regulations and standards.
The advanced wound care market is a dynamic and evolving market, with a high potential for growth and innovation. The report provides a comprehensive and in-depth analysis of the market, covering the market size and forecast, the market segmentation, the growth factors, the competitive landscape, the market trends and the future outlook. The report also provides actionable insights and recommendations for the market players and the stakeholders, to help them capitalize on the market opportunities and overcome the market challenges.
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA